Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9,614,000
-
Total 13F shares
-
21,658,200
-
Share change
-
+21,658,200
-
Total reported value
-
$395,426,446
-
Price per share
-
$18.46
-
Number of holders
-
54
-
Value change
-
+$395,426,626
-
Number of buys
-
54
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q3 2020
As of 30 Sep 2020,
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,658,200 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, VIKING GLOBAL INVESTORS LP, VR Adviser, LLC, Rock Springs Capital Management LP, CITADEL ADVISORS LLC, Avidity Partners Management LP, Logos Global Management LP, JANUS HENDERSON GROUP PLC, and BAKER BROS. ADVISORS LP.
This page lists
54
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.